OYARDI, Ö. Et Al. 2021. In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.76, no.2 , 443-450.

OYARDI, Ö., Savage, P. B., ERTURAN, Z., & Bozkurt-Guzel, C., (2021). In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.76, no.2, 443-450.

OYARDI, ÖZLEM Et Al. "In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis," JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.76, no.2, 443-450, 2021

OYARDI, ÖZLEM Et Al. "In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis." JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.76, no.2, pp.443-450, 2021

OYARDI, Ö. Et Al. (2021) . "In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis." JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.76, no.2, pp.443-450.

@article{article, author={ÖZLEM OYARDI Et Al. }, title={In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis}, journal={JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY}, year=2021, pages={443-450} }